Challenging the Guidelines: Rethinking Neoadjuvant Therapy for Histologic Subtypes of Bladder Cancer

Miguel Zugman1, Ariê Carneiro2, Fernando C Maluf3

  • 1Department of Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA; Centro de Oncologia e Hematologia Einstein Família Dayan-Daycoval, Hospital Israelita Albert Einstein, São Paulo, Brazil.

European Urology
|September 18, 2025
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos